Call for Abstracts

2026 Multidisciplinary Radiopharmaceutical Therapy Symposium (February 17-18, 2026)
Palm Desert, CA

General Instructions

Welcome to ASTRO's Abstract Submission site. Scientific abstracts presented at the 2026 Multidisciplinary Radiopharmaceutical Therapy Symposium offer attendees the opportunity to share key findings with colleagues and engage with leading experts in the field. We employ rigorous guidelines for submissions, so please review all information prior to your submission.

There is a $75 fee per abstract that is non-refundable. Notification of acceptance will be sent to the presenting author only. We will have two rounds of notifications:

The first round will be sent on November 20 to authors who submitted by October 8, notifying accepted authors and noting that session details (oral, plenary or poster) will be shared on December 12.

The final round will be sent on December 12, which will include all final outcomes and session details for both rounds of submissions.

The review process is double-anonymized, so please do not include institution or commercial names in the title or body of your abstract.

No names or titles should be included in the abstract text. Names will be automatically hidden during the abstract review process and will be automatically inserted and properly formatted upon publication. Presenting authors will be automatically informed of the unique ID numbers and passwords assigned to their abstracts. Abstracts may be viewed and modified at any time between submission and the deadline, using the assigned ID# and password.

Technical Support

For help in submitting an abstract online, Contact technical support.

Begin a submission to the following:

RESEARCH ABSTRACT

Present original, completed research or a substantial portion of it.

Deadline for New Submissions: Friday, November 21, 2025 at 11:59 PM Pacific Time

CLINICAL TRIALS IN PROGRESS

Present ongoing or imminent clinical research where final data may not yet be available. The goal is to inform the community about the study design, rationale, and anticipated impact; not results. The trial should have an NCI registration (NCT) identifier.

Deadline for New Submissions: Friday, November 21, 2025 at 11:59 PM Pacific Time

PROGRAM MODEL/BEST PRACTICES

Share implementation or evaluation of a program, service, or project.

Deadline for New Submissions: Friday, November 21, 2025 at 11:59 PM Pacific Time